These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11434453)

  • 21. Amlodipine: an effective once-daily antihypertensive agent.
    Tyler HM
    J Hum Hypertens; 1991 Aug; 5 Suppl 1():61-6. PubMed ID: 1834848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The long-term efficacy and safety profile of barnidipine.
    Smilde JG
    Int J Clin Pract Suppl; 2000 Nov; (114):20-6. PubMed ID: 11221291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Amlodipine: pharmacokinetic and pharmacodynamic profile of a calcium antagonist with prolonged effect].
    Heynen G
    Schweiz Rundsch Med Prax; 1992 Feb; 81(7):199-203. PubMed ID: 1531545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
    Friedel HA; Sorkin EM
    Drugs; 1988 Dec; 36(6):682-731. PubMed ID: 3065058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Azelnidipine.
    Wellington K; Scott LJ
    Drugs; 2003; 63(23):2613-21; discussion 2623-4. PubMed ID: 14636080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barnidipine, a long-acting slow onset calcium antagonist.
    Korstanje C
    Int J Clin Pract Suppl; 2000 Nov; (114):2-5. PubMed ID: 11221290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manidipine: a review of its use in hypertension.
    Cheer SM; McClellan K
    Drugs; 2001; 61(12):1777-99. PubMed ID: 11693466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of barnidipine in comparison with hydrochlorothiazide on endothelial function, as assessed by flow mediated vasodilatation in hypertensive patients.
    Muiesan ML; Salvetti M; Belotti E; Paini A; Rosei CA; Aggiusti C; Scotti A; de Ciuceis C; Rizzoni D; Rosei EA
    Blood Press; 2011 Aug; 20(4):244-51. PubMed ID: 21332412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Atenolol/nifedipine combination: efficacy and tolerability of low dose synergistic bitherapy in the treatment of arterial hypertension].
    Krivitzky A; Nguyen G; Gaudouen Y; Legrand M; Cohen R
    Drugs; 1998; 56 Suppl 2():31-43. PubMed ID: 9813740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension.
    Lee CR; Bryson HM
    Drugs; 1994 Aug; 48(2):274-96. PubMed ID: 7527328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus.
    Derosa G; Querci F; Franzetti I; Dario Ragonesi P; D'Angelo A; Maffioli P
    Hypertens Res; 2015 Oct; 38(10):690-4. PubMed ID: 25994603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term haemodynamic effects of amlodipine at rest and during exercise in essential hypertension.
    Lund-Johansen P; Omvik P; White W; Digranes O; Helland B; Jordal O; Stray T
    Postgrad Med J; 1991; 67 Suppl 5():S20-3. PubMed ID: 1839433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natriuretic effect of barnidipine, a long-acting dihydropyridine calcium channel blocker, in patients with essential hypertension.
    Ohya Y; Abe I; Ohta Y; Onaka U; Fujii K; Kagiyama S; Fujishima-Nakao Y; Fujishima M
    Int J Clin Pharmacol Ther; 2000 Jun; 38(6):304-8. PubMed ID: 10890579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of calcium channel antagonists in the treatment of pediatric hypertension.
    Sahney S
    Paediatr Drugs; 2006; 8(6):357-73. PubMed ID: 17154643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension.
    Tocci G; Desideri G; Roca E; Calcullo C; Crippa M; De Luca N; Gaudio GV; Lonati LM; Orselli L; Scuteri A; Vulpis V; Acone B; Zaninelli A;
    High Blood Press Cardiovasc Prev; 2018 Mar; 25(1):25-34. PubMed ID: 29197935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium antagonists for antihypertensive baseline therapy. First International Nitrendipine Symposium. Interlaken, April 13-14, 1984.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S929-1113. PubMed ID: 6085378
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacology of the dihydropyridine calcium antagonists: relationship between lipophilicity and pharmacodynamic responses.
    van Zwieten PA; Pfaffendorf M
    J Hypertens Suppl; 1993 Dec; 11(6):S3-8. PubMed ID: 8169379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitrendipine and other calcium entry blockers (calcium antagonists) in hypertension.
    Kazda S; Garthoff B; Knorr A
    Fed Proc; 1983 Feb; 42(2):196-200. PubMed ID: 6822291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.